GOLEMBIEWSKI MICHAEL JOSEPH enters SEELOS THERAPEUTICS, INC. with 65.99K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 9/2/2021ACC: 0001136261-21-000206
Officer· Chief Financial Officer
Since Sep 2021
65.99K
Baseline shares
100% direct
65.99K
Direct ownership
1 position
664.71K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned65.99K
Total
65.99K direct65.99K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 65.99K | Direct |
| Total | 65.99K | 65.99K direct |
Derivative Holdings4
Stock option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
62.50K
Shares owned
N/A
Exercise price
2.20
Expiration
—
Exercise window
—
Stock option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
100K
Shares owned
N/A
Exercise price
1.42
Expiration
—
Exercise window
—
Stock option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
190K
Shares owned
N/A
Exercise price
4.31
Expiration
—
Exercise window
—
Stock option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
312.21K
Shares owned
N/A
Exercise price
1.08
Expiration
—
Exercise window
—
Total
Underlying
664.71K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock | 2.20 | — | — | 62.50K | N/A |
| Stock option (right to buy) Direct | Common Stock | 1.42 | — | — | 100K | N/A |
| Stock option (right to buy) Direct | Common Stock | 4.31 | — | — | 190K | N/A |
| Stock option (right to buy) Direct | Common Stock | 1.08 | — | — | 312.21K | N/A |
| Total | 664.71K | 0.00 | ||||